Clinical efficacy, safety, and tolerability of once-daily fesoterodine in subjects with overactive bladder.
暂无分享,去创建一个
A. Tubaro | C. Chapple | M. Brodsky | P. V. van Kerrebroeck | Joseph T. Wang | C. Haag‐Molkenteller | H. Forst | U. Massow | Ute Massow